Blauenfeldt Rolf Ankerlund, Waller Jennifer, Drasbek Kim Ryun, Bech Jesper Nørgaard, Hvas Anne-Mette, Larsen Julie Brogaard, Andersen Morten Nørgaard, Nielsen Marlene Christina, Kjølhede Maria, Kjeldsen Mathilde, Gude Martin Faurholdt, Khan Mohammad Badruzzaman, Baban Babak, Andersen Grethe, Hess David Charles
Department of Neurology (R.A.B., M. Kjølhede, G.A.), Aarhus University Hospital, Denmark.
Department of Clinical Medicine (R.A.B., J.N.B., M.N.A., M.F.G., G.A.), Aarhus University, Denmark.
Stroke. 2025 Mar;56(3):603-612. doi: 10.1161/STROKEAHA.124.048976. Epub 2025 Jan 30.
Remote ischemic conditioning (RIC) is a simple and low-cost intervention that is thought to increase collateral blood flow through the vasodilatory effects of nitric oxide (NO) produced by the endothelium and red blood cells (RBCs). This study aims to investigate whether RIC affects RBC deformability and levels of NO and nitrite in patients with ischemic stroke.
This is a predefined substudy to the RESIST (Remote Ischemic Conditioning in Patients With Acute Stroke Trial) randomized clinical trial conducted in Denmark. RIC was started in the ambulance and continued at the hospital for seven days. Blood samples were collected at different time points: prehospital in the ambulance, in-hospital upon arrival, 2 hours postadmission, and 24 hours postadmission. RBC deformability and erythrocyte aggregation rate were assessed using ektacytometry, NO using flowcytometry, and nitrite content using ozone chemiluminescence.
Of 1500 prehospital randomized patients, 486 patients were included in this study between July 28, 2020, and November 11, 2023, and had blood samples taken. Of these, 249 (51%) had AIS, and here RIC treatment was not associated with increased RBC maximal deformability (RIC, 0.549; sham, 0.548; =0.31), RBC NO (RIC, 35 301 median fluorescence intensity; sham, 34979 median fluorescence intensity; =0.89), or nitrite (RIC, 0.036 µmol/L; sham, 0.034 µmol/L; =0.38), but RIC treatment was associated with a significantly reduced aggregation pressure and a slower erythrocyte aggregation rate (RIC, 323.76 millipascal; sham, 352.74 millipascal; =0.0113).
Prehospital and in-hospital RIC significantly reduced erythrocyte aggregation rate in patients with acute ischemic stroke, while there was no change in RBC deformability, NO content, or whole blood nitrite levels.
URL: https://www.clinicaltrials.gov; Unique identifier: NCT03481777.
远程缺血预处理(RIC)是一种简单且低成本的干预措施,被认为可通过内皮细胞和红细胞(RBC)产生的一氧化氮(NO)的血管舒张作用来增加侧支血流。本研究旨在调查RIC是否会影响缺血性中风患者的红细胞变形性以及NO和亚硝酸盐水平。
这是对在丹麦进行的RESIST(急性中风患者远程缺血预处理试验)随机临床试验的一项预先定义的子研究。RIC在救护车上开始,并在医院持续进行7天。在不同时间点采集血样:在救护车上的院前阶段、入院时、入院后2小时和入院后24小时。使用激光衍射血细胞分析仪评估红细胞变形性和红细胞聚集率,使用流式细胞术评估NO,使用臭氧化学发光法评估亚硝酸盐含量。
在1500例院前随机分组的患者中,2020年7月28日至2023年11月11日期间有486例患者纳入本研究并采集了血样。其中,249例(51%)患有急性缺血性卒中(AIS),在此类患者中,RIC治疗与红细胞最大变形性增加无关(RIC为0.549;假手术组为0.548;P = 0.31),与红细胞NO无关(RIC为35 301中位荧光强度;假手术组为34979中位荧光强度;P = 0.89),也与亚硝酸盐无关(RIC为0.036 μmol/L;假手术组为0.034 μmol/L;P = 0.38),但RIC治疗与聚集压力显著降低和红细胞聚集率减慢有关(RIC为323.76毫帕斯卡;假手术组为352.74毫帕斯卡;P = 0.0113)。
院前和院内RIC显著降低了急性缺血性中风患者的红细胞聚集率,而红细胞变形性、NO含量或全血亚硝酸盐水平无变化。